Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain–Barré Syndrome – a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death. While there have been several reports of Guillain–Barré Syndrome following COVID-19, this is the first in which COVID-19 actually triggered a recurrence of the condition – in a 54-year-old man who had suffered with Guillain–Barré Syndrome twice and had a third occurrence after testing positive for COVID-19, according to the Rutgers case report published in the journal Pathogens. To read the full story.
Home / News / Rutgers Reports First Instance of COVID-19 Triggering Recurrent Guillain-Barré Syndrome
Recent Posts
- NJACTS Community Engagement Core Available Services
- Are You Getting Enough Sleep? Probably Not.
- Using Artificial Intelligence and Innovative Design to Save Patient’s Lives During the COVID19 Pandemic.
- NJIT Machine Learning Expert Pan Xu Combats COVID Vaccine Inequity.
- Join in: “Oh the Possibilities: Careers in Clinical Research” Apr 17, 2023 6:00 pm